Ovid Therapeutics Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+63.8% +$59M
$151M
Current Assets↑+32.9% +$18M
$74M
Cash & Equivalents↓-50.0% -$13M
$13M
Net PPE↓-41.8% -$181K
$252K
Intangibles↓-100.0% -$100K
$0
Total Liabilities↓-15.3% -$4M
$20M
Current Liabilities↓-21.2% -$2M
$8M
Account Payables↓-38.7% -$1M
$2M
Stockholders Equity↑+91.5% +$62M
$131M
Retained Earnings↓-5.7% -$17M
$-322M
Operating Lease ROU Asset↓-9.3% -$1M
$12M
Operating Lease Liability↓-10.7% -$1M
$12M
Accumulated Depreciation↑+12.9% +$181K
$2M
Contract Liability
$718K